These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3048803)

  • 21. Monoclonal antibodies IPO-3 and IPO-10 against human B cell differentiation antigens.
    Pinchouk VG; Sidorenko SP; Gluzman DF; Vetrova EP; Berdova AG; Schlapatskaya LN
    Anticancer Res; 1988; 8(6):1377-80. PubMed ID: 3265315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Juvenile chronic myelogenous leukemia: surface antigen phenotyping by monoclonal antibodies and cytogenetic studies.
    Shannon K; Nunez G; Dow LW; Weinberg AG; Sato Y; Stastny P; Buchanan GR
    Pediatrics; 1986 Mar; 77(3):330-5. PubMed ID: 3513115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
    Tong AW; Lee J; Stone MJ
    Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cytoplasmic expression of CD3 antigens in normal and malignant cells of the T lymphoid lineage.
    Campana D; Thompson JS; Amlot P; Brown S; Janossy G
    J Immunol; 1987 Jan; 138(2):648-55. PubMed ID: 3098852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A monoclonal antibody with reactivity restricted to normal and neoplastic plasma cells.
    Anderson KC; Bates MP; Slaughenhoupt B; Schlossman SF; Nadler LM
    J Immunol; 1984 Jun; 132(6):3172-9. PubMed ID: 6427334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Phenotypic analysis of myeloma cells].
    Mihara K; Harada H; Kawano MM
    Nihon Rinsho; 1995 Mar; 53(3):574-9. PubMed ID: 7699888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibody-defined B-cell, T-cell and myelomonocytic antigens and other surface determinants on leukemic B cells of chronic lymphocytic leukemia.
    Han T; Ozer H; Minowada J
    Prog Clin Biol Res; 1983; 133():135-44. PubMed ID: 6604920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
    Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Almeida J; Orfao A; Mateo G; Ocqueteau M; García-Sanz R; Moro MJ; Hernandez J; Ortega F; Borrego D; Barez A; Mejido M; San Miguel JF
    Pathol Biol (Paris); 1999 Feb; 47(2):119-27. PubMed ID: 10192879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of plasma cell dyscrasias by antibody-mediated immunotherapy.
    Treon SP; Shima Y; Preffer FI; Doss DS; Ellman L; Schlossman RL; Grossbard ML; Belch AR; Pilarski LM; Anderson KC
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):97-106. PubMed ID: 10561024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
    Maruyama S; Kubagawa H; Cooper MD
    J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of the monoclonal antibody WR17, identifying the CD37 gp40-45 Kd antigen complex, in the diagnosis of B-lymphoid malignancy.
    Moore K; Cooper SA; Jones DB
    J Pathol; 1987 May; 152(1):13-21. PubMed ID: 3305845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-cell antigen-positive multiple myeloma.
    Spier CM; Grogan TM; Durie BG; Richter LC; Vela E; Frutiger Y; Rangel CS
    Mod Pathol; 1990 May; 3(3):302-7. PubMed ID: 2194213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD23 expression in plasma cell myeloma is specific for abnormalities of chromosome 11, and is associated with primary plasma cell leukaemia in this cytogenetic sub-group.
    Walters M; Olteanu H; Van Tuinen P; Kroft SH
    Br J Haematol; 2010 Apr; 149(2):292-3. PubMed ID: 20064156
    [No Abstract]   [Full Text] [Related]  

  • 35. Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells.
    Pellat-Deceunynck C; Bataille R; Robillard N; Harousseau JL; Rapp MJ; Juge-Morineau N; Wijdenes J; Amiot M
    Blood; 1994 Oct; 84(8):2597-603. PubMed ID: 7522634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunophenotypic analysis of lymphocytes and myeloma cells in patients with multiple myeloma.
    Shimazaki C; Fried J; Perez AG; Scheinberg DA; Atzpodien J; Wang CY; Wisniewolski R; Clarkson BD
    Acta Haematol; 1990; 83(3):123-9. PubMed ID: 2109450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Questions concerning plasma cell leukaemia.
    Lortholary P; Casassus P; Eclache V
    Nouv Rev Fr Hematol (1978); 1992; 34(3):225-31. PubMed ID: 1408733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunophenotypic spectrum of plasma cell leukemia.
    Linden MD; Fishleder AJ; Tubbs RR; Park H
    Cancer; 1989 Mar; 63(5):859-62. PubMed ID: 2914294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High concordance between marker profiles of 22 human leukemia-lymphoma cell lines tested with the same monoclonal antibodies before and during the second international workshop on human differentiation antigens.
    Drexler HG; Gignac S; Misra B; Skowron L; Menon M; Minowada J
    Cancer Immunol Immunother; 1985; 20(1):75-9. PubMed ID: 3851697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for monoclonal antibodies to human cellular and soluble antigens.
    Eskinazi DP; Eby WC; Molinaro GA
    Methods Enzymol; 1986; 121():783-96. PubMed ID: 3523139
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.